The Carlyle Group Inc.
CG · NASDAQ
Analyst ratings
buy · 12 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 13, 2026 | Evercore ISI Group | Maintains | In-Line | $48.00 |
| July 13, 2026 | RBC Capital | Maintains | Sector Perform | $56.00 |
| July 9, 2026 | Barclays | Maintains | Overweight | $57.00 |
| July 9, 2026 | Citizens | Maintains | Market Outperform | $70.00 |
| May 18, 2026 | TD Cowen | Maintains | Hold | $50.00 |
| May 8, 2026 | TD Cowen | Downgrades | Hold | $53.00 |
| May 8, 2026 | JP Morgan | Maintains | Neutral | $63.00 |
| May 8, 2026 | Barclays | Maintains | Overweight | $63.00 |
| April 30, 2026 | JP Morgan | Maintains | Neutral | $66.00 |
| April 21, 2026 | Morgan Stanley | Maintains | Equal-Weight | $66.00 |
| April 21, 2026 | Evercore ISI Group | Maintains | In-Line | $56.00 |
| April 8, 2026 | Barclays | Maintains | Overweight | $67.00 |
| April 7, 2026 | Goldman Sachs | Maintains | Buy | $69.00 |
| March 24, 2026 | BMO Capital | Maintains | Outperform | $58.00 |
| March 2, 2026 | Barclays | Maintains | Overweight | $68.00 |
| February 27, 2026 | TD Cowen | Maintains | Buy | $67.00 |
| February 27, 2026 | RBC Capital | Maintains | Outperform | $69.00 |
| February 20, 2026 | UBS | Maintains | Buy | $65.00 |
| February 10, 2026 | JP Morgan | Maintains | Neutral | $67.00 |
| February 9, 2026 | Barclays | Maintains | Overweight | $71.00 |
| January 22, 2026 | Evercore ISI Group | Maintains | In-Line | $62.00 |
| January 14, 2026 | TD Cowen | Maintains | Buy | $76.00 |
| January 13, 2026 | UBS | Maintains | Buy | $81.00 |
| December 15, 2025 | Barclays | Maintains | Overweight | $65.00 |
| December 12, 2025 | Barclays | Maintains | Overweight | $68.00 |
| November 3, 2025 | Citigroup | Maintains | Buy | $71.00 |
| November 3, 2025 | TD Cowen | Maintains | Buy | $77.00 |
| November 3, 2025 | Keefe, Bruyette & Woods | Maintains | Market Perform | $64.00 |
| November 3, 2025 | JP Morgan | Maintains | Neutral | $66.00 |
| November 3, 2025 | Evercore ISI Group | Maintains | In-Line | $57.00 |
| October 21, 2025 | Morgan Stanley | Maintains | Equal-Weight | $67.00 |
| October 16, 2025 | JP Morgan | Maintains | Neutral | $68.00 |
| October 13, 2025 | Citigroup | Maintains | Buy | $74.00 |
Valuation reset and price target dispersion
The alternative asset management sector trades at just 12 times next-twelve-months price-to-earnings versus a 20 times historical average, representing a compelling discount. Institutional flows, deployment, and fee-related earnings margins have held up, suggesting the sector can outperform even if only Street estimates are met.
Analyst conviction has been softening, with average ratings deteriorating from 1.93 toward 'Hold' as the stock appreciated. The wide dispersion in analyst price targets — ranging from $31 to $66 with a standard deviation of $9.13 — signals significant uncertainty about Carlyle's fair value and future direction.
Earnings performance and revenue shortfall risk
Carlyle reported $808.7M in net income for 2025 on $3.21B in revenue, and the consensus price target implies roughly 21–30% upside from current levels. Analysts maintaining outperform ratings argue that current Street estimates already embed caution and that performance is delivering in line with expectations.
Carlyle's Q1 2026 earnings disclosed a significant shortfall, with EPS of $0.89 missing the $1.00 forecast and revenue coming in at $254 million against an anticipated $1.06 billion. Earnings have also missed estimates in two of the last three quarters, raising concerns about execution and growth consistency.
Stock price recovery potential amid a prolonged drawdown
Technical analysis points to strong buy signals from both short- and long-term moving averages, with the stock up nearly 45% from its May 2025 pivot bottom. The stock is currently trading slightly below its estimated fair value, suggesting meaningful upside potential for investors with a longer time horizon.
Carlyle's stock hit a 52-week low in June 2026, declining 28.67% over six months and 15.12% over the prior year. RBC Capital cut its price target from $58 to $56 while maintaining only a Sector Perform rating, and Citizens also trimmed its target from $75 to $70, reflecting persistent headwinds.